Hematologic Malignancy
B-Cell Non-Hodgkin Lymphoma
CI-CAN-00000471Explore in graph →
Hematologic1,757 active trials43 approved drugs73 evidence items
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000471Explore in graph →
Rankings
13 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.
| Metric | Scope | Rank / eligible | Δ | Value | Percentile | Confidence | Formula | Generated | Inputs |
|---|---|---|---|---|---|---|---|---|---|
| Curated clinical evidence items | World · both sexes · all ages · latest · all malignant entities | #58 / 492 | = | 73 count | 88.4 | Medium confidence | ci-civic-evidence-v1 | Sep 30, 2026 | showformula: COUNT(civic_evidence_items) WHERE status = ACCEPTED AND cancer_id IN descendants(cancer)
inputs hash 00ec4259c26ee135c931f5a6 Trace lineage (admin) |
| Genes with curated or cohort evidence | World · both sexes · all ages · latest · all malignant entities | #63 / 521 | = | 379 count | 88.1 | Medium confidence | ci-genes-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT gene) FROM (civic accepted evidence ∪ gdc frequency ≥ 0.05 AND cases_affected ≥ 20)
inputs hash dc02edfbbd5b601934401df4 Trace lineage (admin) |
| Public genomic cohorts | World · both sexes · all ages · latest · all malignant entities | #52 / 296 | = | 25 count | 82.7 | Medium confidence | ci-cohorts-v1 | Sep 30, 2026 | showformula: COUNT(genomic_cohorts) WHERE cancer_id IN descendants(cancer)
inputs hash 401b2e31f9813fbae9c90ab7 Trace lineage (admin) |
| Publications, last 12 months | World · both sexes · all ages · latest · all malignant entities | #40 / 2,294 | = | 3,751 count | 98.3 | Medium confidence | ci-pubs-12m-v1 | Sep 30, 2026 | showformula: literature_counts.count WHERE window_key = 12m
inputs hash b1963bee32e72b8b6e51efec Trace lineage (admin) |
| Publications, last 5 years | World · both sexes · all ages · latest · all malignant entities | #44 / 2,873 | = | 18,128 count | 98.5 | Medium confidence | ci-pubs-5y-v1 | Sep 30, 2026 | showformula: literature_counts.count WHERE window_key = 5y (query stored per row)
inputs hash 7b01855837dd178dff17a0c3 Trace lineage (admin) |
| Publication growth | World · both sexes · all ages · latest · all malignant entities | #114 / 286 | = | 1.2 ratio | 60.4 | Medium confidence | ci-pub-growth-v1 | Sep 30, 2026 | showformula: publications_12m / (publications_5y_prior / 5)
inputs hash f24de54682c3ca3c4a7306df Trace lineage (admin) |
| Trial registration growth (year over year) | World · both sexes · all ages · latest · all malignant entities | #99 / 186 | = | 0.07 ratio | 47 | High confidence | ci-trial-growth-v1 | Sep 30, 2026 | showformula: (new_trials_12m − new_trials_prior_12m) / new_trials_prior_12m (first_posted_date windows; interventional; descendants)
|
| Active clinical trials | World · both sexes · all ages · latest · all malignant entities | #21 / 1,654 | = | 1,757 count | 98.8 | Medium confidence | ci-active-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING)
inputs hash d8f333d5bfdbadb41c05f9e2 Trace lineage (admin) |
| Active Phase III trials | World · both sexes · all ages · latest · all malignant entities | #22 / 810 | = | 226 count | 97.4 | Medium confidence | ci-phase3-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) … active statuses AND PHASE3 = ANY(phases)
inputs hash 55bad1a93f2cbb5682249863 Trace lineage (admin) |
| Recruiting clinical trials | World · both sexes · all ages · latest · all malignant entities | #25 / 1,284 | = | 906 count | 98.1 | Medium confidence | ci-recruiting-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL
inputs hash 00002505dcded3e0217a182d Trace lineage (admin) |
| Recruiting Phase III trials | World · both sexes · all ages · latest · all malignant entities | #26 / 585 | = | 103 count | 95.7 | High confidence | ci-phase3-recruiting-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND PHASE3 = ANY(phases) AND study_type = INTERVENTIONAL
inputs hash 3f7191c10405ddd12eec0cad Trace lineage (admin) |
| Sponsor concentration (HHI) | World · both sexes · all ages · latest · all malignant entities | #560 / 614 | = | 0.009 index (0–1) | 8.8 | High confidence | ci-sponsor-hhi-v1 | Sep 30, 2026 | showformula: Σ (active_trials_by_lead_sponsor / active_trials)² over the cancer and its descendants
|
| Trial termination share | World · both sexes · all ages · latest · all malignant entities | #203 / 454 | = | 0.35 ratio | 55.4 | High confidence | ci-trial-termination-v1 | Sep 30, 2026 | showformula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL
|
Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.
"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.
inputs hash ec2dd4ae395f2a38f792c30e
inputs hash 909c6c96975dbbd1461c83c4
inputs hash aebac3d92951539ea771c6d9
Unmet need · computed
No research-gap components for this entity